Tesamorelin / Ipamorelin is a research blend built around two peptides studied for stimulating growth hormone-related pathways through different mechanisms. Researchers are interested in this combination because it may support growth hormone signaling, recovery research, body composition studies, and metabolic function.
Scientific Information
- Full Name: Tesamorelin / Ipamorelin Blend
- Structure: This combination pairs a GHRH analog with a growth hormone secretagogue, allowing researchers to study complementary stimulation of growth hormone release pathways.
Research & Potential Benefits
-
Growth Hormone Pathway Research:
Tesamorelin and ipamorelin act through different signaling pathways that are both involved in endogenous growth hormone release. (Reference 1, 2) -
Recovery Research:
Growth hormone-related peptides are frequently studied for their possible roles in recovery, repair, and restorative physiology. (Reference 1, 3) -
Body Composition Research:
Tesamorelin has been studied for effects on body composition, while ipamorelin has been researched for growth hormone secretagogue activity. (Reference 1, 2) -
Metabolic Function Research:
Researchers also examine these pathways for broader effects on metabolism and endocrine signaling. (Reference 2, 3)
References
- Falutz, J. et al. “Effects of tesamorelin on visceral adipose tissue and metabolic markers.” New England Journal of Medicine.
- Raun, K. et al. “Ipamorelin, the first selective growth hormone secretagogue.” European Journal of Endocrinology.
- Johansen, P.B. et al. “Ipamorelin, a new growth-hormone-releasing peptide with specific GH-releasing properties.” Growth Hormone & IGF Research.
Disclaimer
For Research Use Only. Not for human consumption.
